Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Yixin Biotechnology develops and manufactures advanced nano-enabled diagnostic reagents—primarily functionalized nanomagnetic beads, sample pretreatment agents, nucleic acid extraction/purification kits—and has successfully commercialized several CE-marked products including a monkeypox virus PCR kit. The company’s cleanroom manufacturing supports high-volume production of IVD components. It also pursues early-stage research into small molecules for oncology and cell therapy tools but its main business remains molecular diagnostics with strong technological capabilities in nanoparticle engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Yixin Biotechnology.